Entera Bio Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Entera Bio Ltd. Earnings Date And Information
Entera Bio Ltd. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.03. The company had revenue of 42,000 for the quarter and had revenue of 0 for the year. Entera Bio Ltd. has generated $0 earnings per share over the last year ($-0.31 diluted earnings per share) and currently has a price-to-earnings ratio of -19.45. Entera Bio Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based on prior year's report dates.
Entera Bio Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.05 | $0.08 | 0.13 | $40,000 | $42,000 |
| 08/09/2024 | Q2 2024 | -$0.06 | -$0.06 | 0 | $57,000 | $57,000 |
| 05/10/2024 | Q1 2024 | -$0.06 | -$0.05 | 0.01 | $0 | |
| 03/08/2024 | Q4 2023 | -$0.08 | -$0.07 | 0.01 | $4.48 M | |
| 09/29/2023 | Q3 2023 | -$0.08 | $0 | |||
| 08/11/2023 | Q2 2023 | -$0.07 | -$0.08 | -0.01 | $0 | |
| 05/05/2023 | Q1 2023 | -$0.12 | $0.08 | 0.2 | $0 | |
| 03/31/2023 | Q4 2022 | -$0.12 | -$0.11 | 0.01 | $14,000 | |
| 11/10/2022 | Q3 2022 | -$0.16 | -$0.09 | 0.07 | $70,000 | $8,000 |
| 08/11/2022 | Q2 2022 | -$0.13 | -$0.11 | 0.02 | $100,000 | $44,000 |
| 05/12/2022 | Q1 2022 | -$0.16 | -$0.13 | 0.03 | $68,000 | |
| 11/10/2021 | Q4 2021 | -$0.10 | $1.02 | 1.12 | $165,000 | |
| 11/10/2021 | Q3 2021 | -$0.10 | -$0.09 | 0.01 | $120,000 | $140,000 |
| 05/20/2021 | Q2 2021 | -$0.12 | -$0.21 | -0.09 | $173,000 | $109,000 |
| 05/20/2021 | Q1 2021 | -$0.12 | -$0.10 | 0.02 | $157,000 | |
| 11/19/2020 | Q4 2020 | -$0.20 | -$0.12 | 0.08 | $221,000 | |
| 11/19/2020 | Q3 2020 | -$0.20 | -$0.09 | 0.11 | $50,000 | |
| 05/21/2020 | Q2 2020 | -$0.17 | $36,705 | $52,000 | ||
| 05/21/2020 | Q1 2020 | -$0.16 | $42,000 | |||
| 11/21/2019 | Q4 2019 | -$0.15 | -$0.29 | -0.14 | $102,000 |
Entera Bio Ltd. Earnings: Frequently Asked Questions
-
When is Entera Bio Ltd.'s earnings date?
Entera Bio Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 14th, 2025 based off last year's report dates.
-
How can I listen to Entera Bio Ltd.'s earnings conference call?
The conference call for Entera Bio Ltd.'s latest earnings report can be listened to online.
-
How can I read Entera Bio Ltd.'s conference call transcript?
The conference call transcript for Entera Bio Ltd.'s latest earnings report can be read online.
-
How much profit does Entera Bio Ltd. generate each year?
Entera Bio Ltd. (:ENTX) has a recorded net income of $0. Entera Bio Ltd. has generated $-0.31 earnings per share over the last four quarters.
-
What is Entera Bio Ltd.'s price-to-earnings ratio?
Entera Bio Ltd. (:ENTX) has a price-to-earnings ratio of -19.45 and price/earnings-to-growth ratio is -0.63.
